Sionna Therapeutics Inc (SION)

May 05, 2026

A Look At Sionna Therapeutics (SION) Valuation After Its Strong 1 Year Return And Premium P/B Ratio - Yahoo Finance

May 05, 2026

May 05, 2026

Wedbush initiates Sionna Therapeutics stock with Outperform rating By Investing.com - Investing.com South Africa

May 05, 2026

May 01, 2026

Sionna Insider Sells $2.5 Million in Stock Amid 215% Surge, but Here's What Investors Should Watch - AOL.com

May 01, 2026

May 01, 2026

Sionna Therapeutics, Inc. $SION Shares Acquired by Jennison Associates LLC - MarketBeat

May 01, 2026

Apr 28, 2026

Trial of SION-719 as Trikafta add-on therapy in CF is fully enrolled - Cystic Fibrosis News Today

Apr 28, 2026

Apr 28, 2026

JonesTrading Forecasts Strong Price Appreciation for Sionna Therapeutics (NASDAQ:SION) Stock - MarketBeat

Apr 28, 2026

Apr 28, 2026

Jones Trading raises Sionna Therapeutics price target on trial progress By Investing.com - Investing.com Canada

Apr 28, 2026

Apr 28, 2026

EDGAR Filing Documents for 0001628280-26-027501 - SEC.gov

Apr 28, 2026

Apr 27, 2026

Sionna Therapeutics (NASDAQ: SION) details 2026 virtual meeting, board elections - Stock Titan

Apr 27, 2026

Apr 27, 2026

Sionna Insider Sells $2.5 Million in Stock Amid 215% Surge, but Here's What Investors Should Watch - The Motley Fool

Apr 27, 2026

Apr 27, 2026

Sionna Therapeutics Completes Phase 2a Enrollment for SION-719 in Cystic Fibrosis - marketscreener.com

Apr 27, 2026

Apr 27, 2026

Sionna completes enrollment in cystic fibrosis drug trial By Investing.com - Investing.com Canada

Apr 27, 2026

Apr 27, 2026

Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial for SION-719 in Cystic Fibrosis - Quiver Quantitative

Apr 27, 2026

Apr 27, 2026

First trial of Sionna's CF add-on drug reaches full enrollment - Stock Titan

Apr 27, 2026

Apr 26, 2026

Sionna Therapeutics (SION) Q1 2025 earnings summary - Quartr

Apr 26, 2026

Apr 26, 2026

Sionna Therapeutics (SION) 44th Annual J.P. Morgan Healthcare Conference Summary - Quartr

Apr 26, 2026

Apr 26, 2026

Sionna Therapeutics (SION) Cantor Global Healthcare Conference 2025 Summary - Quartr

Apr 26, 2026

Apr 26, 2026

Sionna Therapeutics (SION) Leerink Global Healthcare Conference 2026 Summary - Quartr

Apr 26, 2026

Apr 26, 2026

Sionna Therapeutics (SION) Q4 2025 earnings summary - Quartr

Apr 26, 2026

Apr 26, 2026

Sionna Therapeutics (SION) Q2 2025 earnings summary - Quartr

Apr 26, 2026

Apr 26, 2026

Sionna Therapeutics (SION) Guggenheim Securities Emerging Outlook: Biotech Summit 2026 summary - Quartr

Apr 26, 2026

Apr 23, 2026

Sionna Therapeutics (NASDAQ:SION) Stock Price Down 11.3%What's Next? - MarketBeat

Apr 23, 2026

Apr 22, 2026

Sionna Therapeutics Insider Sold Shares Worth $2,472,343, According to a Recent SEC Filing - marketscreener.com

Apr 22, 2026

Apr 22, 2026

OrbiMed Advisors sells $2.47m in Sionna Therapeutics stock By Investing.com - Investing.com Australia

Apr 22, 2026

Apr 21, 2026

Sionna Therapeutics (NASDAQ:SION) Director Peter Thompson Sells 52,397 Shares - MarketBeat

Apr 21, 2026

Apr 21, 2026

Sionna Therapeutics (NASDAQ:SION) Director Sells $2,341,097.96 in Stock - MarketBeat

Apr 21, 2026

Apr 21, 2026

Insider Selling: Sionna Therapeutics (NASDAQ:SION) Director Sells 2,948 Shares of Stock - MarketBeat

Apr 21, 2026

Apr 21, 2026

Sionna Therapeutics director Peter A. Thompson sells $2.47m in stock - Investing.com

Apr 21, 2026

Apr 21, 2026

OrbiMed Advisors sells $2.47m in Sionna Therapeutics stock - Investing.com

Apr 21, 2026

Apr 21, 2026

Sionna Therapeutics director Peter A. Thompson sells $2.47m in stock By Investing.com - Investing.com India

Apr 21, 2026

Apr 21, 2026

OrbiMed fund tied to Sionna (NASDAQ: SION) director trims 55K shares - Stock Titan

Apr 21, 2026

Apr 21, 2026

OrbiMed-backed Sionna (NASDAQ: SION) sees fund share sale - Stock Titan

Apr 21, 2026

Apr 21, 2026

Why Sionna Therapeutics Stock Is Sinking Now - TipRanks

Apr 21, 2026

Apr 20, 2026

OrbiMed (SION) cuts Sionna stake to 6.6% after April share sales - Stock Titan

Apr 20, 2026

Apr 18, 2026

Is Sionna Therapeutics (SION) stock expensive relative to growth (-3.76%) 2026-04-18Weak Sell Rating - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 18, 2026

Apr 17, 2026

OrbiMed Advisors sells Sionna Therapeutics (SION) stock worth $22.9m By Investing.com - Investing.com UK

Apr 17, 2026

Apr 16, 2026

Peter Thompson Sells 235,863 Shares of Sionna Therapeutics (NASDAQ:SION) Stock - MarketBeat

Apr 16, 2026

Apr 16, 2026

Orbimed Advisors Llc Sells 235,863 Shares of Sionna Therapeutics (NASDAQ:SION) Stock - MarketBeat

Apr 16, 2026

Apr 16, 2026

Sionna Therapeutics (NASDAQ:SION) Director Peter Thompson Sells 47,814 Shares - MarketBeat

Apr 16, 2026

Apr 16, 2026

Insider Selling: Sionna Therapeutics (NASDAQ:SION) Director Sells 226,906 Shares of Stock - MarketBeat

Apr 16, 2026

Apr 16, 2026

Sionna Therapeutics (SION) director Thompson sells $22.9 million in stock By Investing.com - Investing.com Canada

Apr 16, 2026

Apr 16, 2026

Sionna Therapeutics (SION) director Thompson sells $22.9 million in stock - Investing.com

Apr 16, 2026

Apr 16, 2026

Sionna Therapeutics(SION.US) Director Sells US$22.95 Million in Common Stock - Moomoo

Apr 16, 2026

Apr 16, 2026

OrbiMed Advisors sells Sionna Therapeutics (SION) stock worth $22.9m - Investing.com

Apr 16, 2026

Apr 16, 2026

OrbiMed fund linked to Sionna Therapeutics (SION) director sells 510K shares - Stock Titan

Apr 16, 2026

Apr 16, 2026

OrbiMed entities sell Sionna Therapeutics (SION) stock under 10b5-1 plan - Stock Titan

Apr 16, 2026

Apr 16, 2026

Operating cash flow per share of Sionna Therapeutics, Inc. – NASDAQ:SION - TradingView

Apr 16, 2026

Apr 16, 2026

Sionna Therapeutics stock hits all-time high at 45.17 USD By Investing.com - Investing.com Australia

Apr 16, 2026

Apr 16, 2026

Why Sionna Therapeutics Stock Is Sliding After a Surge - TipRanks

Apr 16, 2026

Apr 16, 2026

Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Apr 16, 2026